Protagenic Therapeutics, Inc.\new (PTIX) Operating Income (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Operating Income of -$961,247 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$1.21 million a year earlier.
Powered by 
Analysis
Protagenic Therapeutics, Inc.\new (PTIX) Operating Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Protagenic Therapeutics, Inc.\new was -$3.12 million; for FY2026 (ended Mar 31, 2026), it was -$4.5 million.
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Operating Income was -$2.59 million in FY2025, -$5.7 million in FY2024, -$4.53 million in FY2023 and -$3.56 million in FY2022.
- Quarterly Operating Income has run from a low of -$1.45 million in fiscal Q4 2025 to a high of -$120,331 in fiscal Q4 2026 over five years.
- According to Business Quant data, Operating Income for the three prior fiscal quarters was -$120,331 (Q4 2026), -$925,103 (Q3 2026) and -$1.11 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.38 Mn | 1.38 Mn | - | -961,247.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -961,247.00 |
| Mar 31, 2026 | -120,331.00 |
| Dec 31, 2025 | -925,103.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.21 Mn |
| Mar 31, 2025 | -1.45 Mn |
| Dec 31, 2024 | -401,401.00 |
| Sep 30, 2024 | -355,374.00 |
| Jun 30, 2024 | -1.67 Mn |
| Mar 31, 2024 | -1.74 Mn |
| Dec 31, 2023 | -1.21 Mn |
| Sep 30, 2023 | -1.43 Mn |
| Jun 30, 2023 | -1.14 Mn |
| Mar 31, 2023 | -739,294.00 |
| Dec 31, 2022 | -655,778.00 |
| Sep 30, 2022 | -924,060.00 |
| Jun 30, 2022 | -636,674.00 |
| Mar 31, 2022 | -1.34 Mn |
| Dec 31, 2021 | -861,219.00 |
| Sep 30, 2021 | -764,171.00 |
API Access
Protagenic Therapeutics, Inc.\new Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=PTIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();